Best evidence-based treatments for melasma

Melasma is one of the most stubborn skin conditions a dermatologist treats. It shows up as brown or gray-brown patches, usually on the cheeks, forehead, upper lip, and bridge of the nose, and it has a frustrating habit of coming back the moment you slack on treatment. The good news is that decades of clinical trials now point to a handful of therapies that genuinely move the needle. The bad news is that many of the most-hyped options have thin evidence, real risks, or a high relapse rate. This guide walks through what actually works, how strong the proof is, and where the marketing runs ahead of the science.

What melasma actually is

Melasma is a chronic disorder of excess pigment. Specialized skin cells called melanocytes produce too much melanin and deposit it in the upper layers of the skin (epidermal melasma), the deeper layers (dermal melasma), or both (mixed). Where the pigment sits matters a lot, because epidermal pigment responds far better to creams than pigment buried deeper in the skin.

Three forces drive most cases:

Sun exposure, including ultraviolet light AND visible light. This is the single biggest controllable trigger.
Hormones, especially estrogen and progesterone. Pregnancy ("the mask of pregnancy"), birth control pills, and hormone therapy are common triggers.
Genetics and skin tone. Melasma overwhelmingly affects women and is far more common in people with medium-to-deep skin tones (Fitzpatrick types III-V).

Newer research also implicates blood vessel growth and a "leaky" lower layer of the epidermis, which is why melasma behaves more like a complex, multi-system problem than a simple pigment stain. The American Academy of Dermatology describes melasma as a condition that can be controlled and improved but not truly cured, which is the honest framing every patient should start with.

Why does this complexity matter for treatment? Because it explains why melasma resists the simple fixes that work on other dark spots. A post-acne mark or a sun spot is a one-time event; clear it and it's gone. Melasma is more like an overactive switch that keeps flipping back on. The melanocytes in melasma skin aren't just making extra pigment, they're also larger, more active, and surrounded by an environment that keeps egging them on. Treat only the surface pigment and you've ignored the machinery underneath. That's the core reason why combination therapy and long-term maintenance beat any single quick fix, and why the conditions that calm melasma (less sun, settled hormones) matter as much as the products you apply.

It's also worth being clear about what melasma is not. It is not a sign of poor hygiene, it is not contagious, and it is not dangerous to your health. It is a cosmetic and psychological burden, and surveys consistently show it takes a real toll on quality of life, which is exactly why so many people chase aggressive treatments and get burned by ones that don't deliver.

A critical point that shapes everything below: melasma is chronic and relapsing. No single treatment is a permanent fix. The realistic goal is to fade the patches, then hold them down with maintenance care and relentless sun protection.

The foundation: photoprotection

If you do nothing else, do this. Photoprotection is the only intervention that is both proven to fade existing melasma and proven to prevent relapse, and it is the base layer that makes every other treatment work better.

For years, people assumed UV was the whole story. It isn't. Short wavelengths of visible light (the blue-violet light around 415 nm that comes from the sun and, to a much smaller degree, screens) can trigger lasting pigmentation in people prone to melasma. Standard clear sunscreens do almost nothing against visible light. That gap is why tinted sunscreens containing iron oxides matter so much.

A prospective, randomized, investigator-blinded study compared a tinted, visible-light-protective sunscreen to an untinted version in melasma patients through the summer. The tinted, iron-oxide formula did a meaningfully better job holding melasma steady during peak sun season. Iron oxides absorb and scatter visible light in a way that clear chemical filters simply cannot.

Photoprotection rules that match the evidence

Use a broad-spectrum SPF 30 or higher, every day, rain or shine.
Choose a tinted mineral sunscreen with iron oxides for visible-light coverage.
Reapply every two hours outdoors.
Add a wide-brimmed hat and shade. Sunscreen alone is never enough for melasma.

Skip the photoprotection and even the best laser or prescription cream will fail. This is not optional background advice. It is the treatment.

Topical treatments: the proven first line

Creams remain the cornerstone of melasma care, and the evidence here is the strongest in the whole field.

Triple combination cream (the gold standard)

The most-studied topical treatment is triple combination cream (TCC), also called Kligman's formula: hydroquinone, a retinoid (tretinoin), and a low-strength corticosteroid. In the U.S., the brand Tri-Luma is the only FDA-approved version. The three ingredients hit melasma from different angles. Hydroquinone blocks the pigment-making enzyme tyrosinase, the retinoid speeds up cell turnover and helps the other ingredients penetrate, and the steroid calms inflammation and reduces irritation.

Dermatology consensus places fixed triple combinations as first-line therapy, and combination approaches reduce relapse compared with single agents. This is about as solid as the evidence gets in melasma.

The catch is hydroquinone itself. It works, but it is not a forever drug.

The hydroquinone reality check

Hydroquinone is effective and, used correctly under supervision, reasonably safe in short cycles. But there are real reasons it now requires a prescription in the United States.

The FDA pulled over-the-counter hydroquinone products from the market in 2020 under the CARES Act, reclassifying them as unapproved drugs. The agency has received reports of serious side effects, including skin rashes, facial swelling, and exogenous ochronosis, a paradoxical blue-black darkening of the skin that can be permanent and is genuinely difficult to treat. Ochronosis usually develops after long, uninterrupted use, and most cases involve higher concentrations or use without sun protection.

The practical takeaway: hydroquinone is a powerful tool used in cycles (often a few months on, then a break with non-hydroquinone maintenance), under a clinician's eye, not a cream you smear on indefinitely.

Non-hydroquinone topicals

Because hydroquinone can't be used forever, a lot of research has gone into alternatives that you can use for maintenance or as a swap.

Cysteamine 5% cream has become the most credible hydroquinone alternative. It is a naturally occurring antioxidant that lowers melanin without the cell-killing effect that drives hydroquinone's worst side effects. In a randomized, double-blinded trial, cysteamine 5% cream produced results comparable to a hydroquinone-based combination over four months. A 2024 systematic review and meta-analysis of randomized trials confirmed cysteamine outperforms placebo at reducing melasma severity. The honest caveats: it can sting, the smell is unpleasant, and head-to-head it tends to land roughly even with hydroquinone rather than clearly beating it.

Azelaic acid 20% is another well-studied option. A systematic review and meta-analysis comparing azelaic acid with hydroquinone found azelaic acid performed at least as well on severity scores, with a comparable side-effect profile. It is gentler and safe for long-term use and pregnancy, which makes it a workhorse for maintenance.

Other topicals with supporting but generally weaker or smaller-trial evidence include niacinamide, kojic acid, ascorbic acid (vitamin C), and topical tranexamic acid. These are reasonable additions, especially for maintenance, but none should be sold as a standalone cure.

A word on how to read topical claims. Many over-the-counter "melasma serums" lean on one of these milder ingredients, slap a clinical-sounding name on the label, and cite a single small study. The honest reading: most of these work modestly at best on their own. They earn their place as gentle maintenance agents or as part of a stack, not as the thing that clears moderate melasma by itself. If a product promises to erase melasma in two weeks, that promise is not coming from the trial data.

It's also worth flagging an emerging-therapy honesty note. You'll see headlines about oral metformin and other off-label ideas for melasma. A few small studies and meta-analyses have looked at metformin and found hints of benefit, but the evidence base is thin, the trials are small, and this is nowhere near established care. The same applies to a long tail of "next big thing" topical actives that surface every year. Promising is not the same as proven. When the evidence is early, treat it as early.

Topical agents at a glance

Topical agent	Evidence strength	Best use	Main drawback
Triple combination cream (HQ + retinoid + steroid)	Strong (first-line consensus)	Active fading phase, in cycles	Steroid and hydroquinone limits; not for long-term use
Hydroquinone (alone)	Strong	Short cycles under supervision	Risk of ochronosis; prescription-only in U.S.
Cysteamine 5%	Moderate (multiple RCTs, meta-analysis)	Hydroquinone alternative / maintenance	Smell, stinging
Azelaic acid 20%	Moderate (RCTs, meta-analysis)	Maintenance, pregnancy-safe option	Slower, can irritate
Niacinamide, kojic acid, vitamin C	Weak-to-moderate (smaller trials)	Adjuncts, maintenance	Modest effect alone
Topical tranexamic acid	Moderate but mixed	Adjunct	Less effective than oral form

Oral tranexamic acid: the most important recent advance

If there's one therapy that has genuinely changed melasma care in the past decade, it's oral tranexamic acid (TXA). Originally a clot-stabilizing drug used to control bleeding, it turned out to quiet melasma through a different pathway. TXA blocks plasmin, which reduces the signals that prod melanocytes into overproducing pigment and may also calm the abnormal blood vessel growth seen in melasma.

The evidence is now substantial. A 2024 meta-analysis and systematic review of randomized controlled trials concluded that tranexamic acid is an effective option for melasma, alone or added to standard treatment, without raising toxicity. Adding oral TXA to triple combination cream produced faster, deeper, and more durable improvement than the cream alone, and lowered relapse rates.

Typical regimens in the studies ran 250-500 mg twice daily for roughly 2-6 months. Dermatology has largely settled on low doses, well below the levels used to stop surgical bleeding.

The safety question, told honestly

Because TXA affects clotting, the obvious worry is blood clots. Here the evidence is reassuring but not a blank check. A large 2025 review of dozens of randomized trials found no thromboembolic events across hundreds of patient-years at the low doses used for melasma. A multicenter cohort study of melasma patients on oral TXA likewise found no increased thromboembolism risk overall, though it included one deep vein thrombosis in a patient later found to have an inherited clotting disorder.

That single case is the whole point of careful prescribing. Oral TXA is not for everyone. It is contraindicated in people with a personal or family history of blood clots, clotting disorders, and certain other conditions, and many clinicians avoid it in people on estrogen birth control or who smoke heavily. Common, milder side effects include lighter periods, mild stomach upset, and occasional headaches. This is a prescription drug that needs a real screening conversation, not something to order online.

Procedures: chemical peels, lasers, and microneedling

When creams plus TXA aren't enough, in-office procedures enter the picture. Here the evidence gets shakier and the risk of making melasma worse gets real, especially in deeper skin tones.

Chemical peels

Superficial chemical peels (glycolic acid, salicylic acid, and others) are a reasonable add-on to topicals. They remove surface pigment and can speed visible improvement. The evidence supports them as an adjunct, not a standalone treatment, and they work best in lighter skin types where the risk of post-peel darkening is lower. Deeper peels carry a higher risk of triggering post-inflammatory hyperpigmentation, which can look worse than the original melasma.

Lasers and light devices

Lasers get marketed aggressively for melasma. The reality is more sobering.

The most-studied device is the low-fluence Q-switched Nd:YAG laser. A systematic review found it can work in the short term, but the recurrence rate ran as high as 81%, and it carried a real risk of mottled hypopigmentation (permanent light spots) and, when used too aggressively, rebound darkening. Older, higher-energy Q-switched lasers produced disappointing results complicated by significant rebound hyperpigmentation.

The honest summary on lasers:

They can help selected patients as part of a combination plan.
Used alone, melasma usually comes back, often within months.
The risk of making pigmentation worse is genuine, particularly in medium-to-deep skin.
This is the area where patient stories and clinic marketing run furthest ahead of the trial data.

If you pursue laser, do it with an experienced provider who treats your skin tone often, who uses conservative settings, and who pairs it with photoprotection and topicals.

Microneedling

Microneedling, often combined with topical tranexamic acid, shows promise in smaller studies, mostly as a way to drive ingredients deeper. The evidence base is still thin and the trials are small. Treat it as promising-but-unproven, not established.

Procedure evidence summary

Procedure	Evidence strength	Recurrence/risk	Verdict
Superficial chemical peels	Moderate (as adjunct)	Risk of PIH, esp. deeper skin	Useful add-on, not standalone
Low-fluence Q-switched Nd:YAG laser	Mixed; short-term only	Up to ~81% recurrence; hypopigmentation risk	Combination use only, cautious settings
Older high-fluence Q-switched lasers	Poor	Significant rebound darkening	Generally avoid
Microneedling + topical TXA	Weak (small studies)	Limited data	Promising, unproven

Building a real treatment plan

The strongest results in melasma never come from one product. They come from stacking proven steps and committing for the long haul. A typical evidence-aligned plan looks like this:

Lock in photoprotection first. Daily tinted mineral SPF with iron oxides, hats, shade. This is non-negotiable.
Start a triple combination cream (or cysteamine/azelaic acid if hydroquinone isn't suitable) for the active fading phase, used in cycles under a clinician.
Add oral tranexamic acid if you're a good candidate and topicals alone aren't enough, after proper screening.
Consider gentle procedures (superficial peels) only as add-ons once pigment is improving.
Transition to maintenance. Swap hydroquinone for cysteamine or azelaic acid, keep up sun protection, and expect to manage this for years.

How long until it works, and how to judge progress

Set expectations early. Topicals and oral TXA typically need 8 to 12 weeks before you see a clear difference, and the fuller benefit often takes several months. Melasma improves slowly and unevenly, so judging by week-to-week mirror checks will only frustrate you. Photographs in the same light, a month apart, are far more honest.

Dermatologists track progress with a tool called the MASI score (Melasma Area and Severity Index), which combines how much skin is affected with how dark and uneven the patches are. In the trials cited here, "success" usually means a meaningful drop in MASI, not perfect, flawless skin. That's a useful frame for your own expectations: aim for substantial fading and easier camouflage, not erasure.

If you've been consistent for three months with strict sun protection and a proven topical and you see nothing, that's the signal to reassess with a clinician rather than to pile on more aggressive (and riskier) procedures on your own.

Why relapse happens, and how to fight it

Relapse is the rule, not the exception, and it almost always traces back to two things: sun exposure creeping back in, and stopping active treatment cold without a maintenance bridge. The combination of these two undoes months of progress fast. The fix is unglamorous but effective. Never fully stop. Step down from active fading agents to a gentler maintenance routine, and never, ever stop the photoprotection. Melasma patients who treat sunscreen as a year-round, every-single-day habit hold their results far better than those who treat it as a summer-only chore.

Who each treatment is for

Mild, epidermal melasma, lighter skin: topical first line plus strict photoprotection often does the job.
Moderate-to-severe or recurring melasma: add oral tranexamic acid (if eligible) to topicals.
Deeper skin tones (Fitzpatrick IV-VI): favor topicals and TXA; be cautious with lasers and deeper peels because the risk of worsening pigment is higher.
Pregnant or breastfeeding: azelaic acid is the go-to; avoid hydroquinone, retinoids, and oral TXA. Often melasma improves on its own after pregnancy and hormones settle.
People with clotting history: oral TXA is off the table; lean on topicals and procedures.

For a closer look at procedure-based options, see our deep dives on the best chemical peels for melasma and the pigmentation laser treatment options compared. If your skin tone shapes your risk profile, our guide to the best laser treatments for dark skin is worth reading before booking anything. For broader facial approaches, see the best facials for hyperpigmentation, and for how trials are designed and read, our overview of clinical studies on beauty treatments.

Frequently Asked Questions

Can melasma be cured permanently?

No. The honest answer, echoed by dermatology consensus, is that melasma is chronic and relapsing. Treatment can dramatically fade it, but it tends to return when sun protection lapses or hormones shift. The realistic goal is long-term control through maintenance and photoprotection, not a one-and-done cure.

Is hydroquinone safe to use for melasma?

Used in short, supervised cycles, hydroquinone is effective and reasonably safe. The risks come from long, uninterrupted use, higher concentrations, and skipping sun protection, which can lead to exogenous ochronosis, a permanent paradoxical darkening. The FDA removed over-the-counter hydroquinone from the U.S. market in 2020, so it now requires a prescription. It works best as a cycled tool, not a daily forever cream.

Does oral tranexamic acid cause blood clots?

At the low doses used for melasma, large reviews of randomized trials have found no increase in clotting events, which is reassuring. But the drug isn't for everyone. People with a personal or family history of clots, clotting disorders, or certain other risk factors should not take it. It requires a screening conversation and a prescription, not a self-ordered supplement.

Do lasers work for melasma?

Sometimes, but they're oversold. The most-studied laser for melasma helped short-term in trials but had recurrence rates as high as 81% and carried a real risk of permanent light spots or rebound darkening, especially in deeper skin tones. Lasers are best used cautiously, as part of a combination plan with an experienced provider, not as a first or standalone option.

What's the single most important thing I can do?

Daily photoprotection, specifically a tinted mineral sunscreen with iron oxides that blocks visible light, not just UV. It's the only step proven both to fade melasma and to prevent relapse, and it's the foundation that makes every cream, pill, and procedure actually work.

This article is for general education and is not medical advice. Melasma treatment, especially prescription creams and oral medications, should be guided by a board-certified dermatologist who can assess your skin type, history, and risk factors. Consult a qualified clinician before starting any treatment.